UCSF

ZINC19418959

Substance Information

In ZINC since Heavy atoms Benign functionality
November 1st, 2008 28 Yes

Other Names:

10-(3-(4-methyl-1-piperazinyl)propyl)-2-(trifluoromethyl)-10H-phenothiazine

10-(3-(4-methyl-1-piperazinyl)propyl)-2-(trifluoromethyl)-phenothiazine

10-(3-(4-Methyl-1-piperazinyl)propyl)-2-(trifluoromethyl)phenothiazine

10-(gamma-(N'-Methylpiperazino)propyl)-2-trifluoromethylphenothiazine

10-[3-(4-Methyl-1-piperazinyl)propyl]-2-(trifluoromethyl)-10H-phenothiazine

10-[3-(4-METHYL-1-PIPERAZINYL)PROPYL]-2-TRIFLUOROMETHYL-PHENOTHIAZINE DIHYDROCHLORIDE

10-[3-(4-METHYL-PIPERAZIN-1-YL)-PROPYL]-2-TRIFLUOROMETHYL-10H-PHENOTHIAZINE

10-[3-(4-methylpiperazin-1-yl)propyl]-2-(trifluoromethyl)-10H-phenothiazine

10-[3-(4-methylpiperazin-1-yl)propyl]-2-(trifluoromethyl)-10H-phenothiazine dihydrochloride

10-[3-(4-methylpiperazin-1-yl)propyl]-2-(trifluoromethyl)phenothiazine

10-[3-(4-methylpiperazin-1-yl)propyl]-2-(trifluoromethyl)phenothiazine dihydrochloride

10-[3-(4-methylpiperazin-1-yl)propyl]-2-(trifluoromethyl)phenothiazine; CPD-7051; trifluoperazine

10H-Phenothiazine, 10-(3-(4-methyl-1-piperazinyl)propyl)-2-(trifluoromethyl)-

10H-Phenothiazine, 10-[3-(4-methyl-1-piperazinyl)propyl]-2-(trifluoromethyl)-

117-89-5

117-89-5; Apo-trifluoperazine (TN); D08636; Trifluoperazine (INN)

117-89-5; C07168; Trifluoperazine

2-Trifluoromethyl-10-(3'-(1-methyl-4-piperazinyl)propyl)phenothiazine

2-Trifluoromethyl-10-(3'-(1-methyl-4-piperazinyl)propyl)phenothiazine dihydrochloride; Trifluoperazine HCl; Trifluoperazine dihydrochloride; Trifluoroperazine dihydrochloride; Trifluperazine dihydrochloride

440-17-5; Prestwick_482; Trifluoperazine dihydrochloride

605-75-4; D01448; Trifluoperazine (TN); Trifluoperazine maleate (JAN)

AB00053558

AC1L1KMT

AC1Q3ZYE

AKOS001487920

Apo-Trifluoperazine

Apo-trifluoperazine (TN)

BIDD:PXR0132

Bio1_000458

Bio1_000947

Bio1_001436

Bio2_000435

Bio2_000915

Biomol-NT_000060

BPBio1_000338

BPBio1_001345

BRD-K89732114-001-02-6

BRD-K89732114-001-03-4

BRD-K89732114-300-05-5

BSPBio_000306

BSPBio_001190

BSPBio_002928

C07168

C21H24F3N3S

Calmazine

CAS-440-17-5

CCRIS 6994

CHEBI:101325

CHEBI:45949; CHEBI:9709

CHEBI:45951

CHEMBL422

CID5566

cMAP_000048

CPD000059133

CPD000059133; SAM001247046; TRIFLUOPERAZINE DIHYDROCHLORIDE

CPD000059133; SAM001247046; Tripfluoperazine Hydrochloride

D08636

DAP000034

DB00831

DB08616

DivK1c_000843

EINECS 204-219-4

Eskazine

Eskazinyl

FDA); Trifluoperazine Maleate (JAN)

Fluoperazine

Flurazine

HMS1362L11

HMS1792L11

HMS1990L11

HMS2089J11

HSDB 3195

IDI1_000843

IDI1_002190

INN); Trifluoperazine HCl (FDA

INN); Trifluoperazine HCl (JAN

INN); Trifluoperazine Maleate (JAN)

JAN

Jatroneural

KBio1_000843

KBio2_000530

KBio2_001148

KBio2_002431

KBio2_003098

KBio2_003716

KBio2_004999

KBio2_005666

KBio2_006284

KBio2_007567

KBio3_000959

KBio3_000960

KBio3_002148

KBio3_002910

KBioGR_000530

KBioGR_000835

KBioGR_002431

KBioSS_000530

KBioSS_001148

KBioSS_002437

L001075

LS-105595

LS-105597; Phenothiazine, 10-(3-(4-methyl-1-piperazinyl)propyl)-2-(trifluoromethyl)-, maleate (1:2); Trifluoperazine dimaleate

MFCD00012656

MFCD00242601

MLS002702821

Modalina

MolPort-001-727-956

N/A

NCGC00013226

NCGC00013226-02

NCGC00013226-03

NCGC00013226-04

NCGC00013226-12

NCGC00024251-03

NCGC00024251-04

NCGC00024251-05

NCGC00024251-06

NCGC00024251-07

nchembio873-comp70

NCI17474

NCI60_001427

NCI60_004087

NCIStruc1_001127

NCIStruc2_001093

NINDS_000843

Novo-Trifluzine

NSC 17474

NSC 46061

NSC-17474

NSC17474

NSC46061

PDSP1_001300

PDSP2_001284

Phenothiazine, 10-(3-(4-methyl-1-piperazinyl)propyl)-2-(trifluoromethyl)-

PMS Trifluoperazine

Prestwick0_000313

Prestwick1_000313

Prestwick2_000313

Prestwick3_000313

QA-7104

QTL1_000085

RP 7623

SKF 5019

SKF-5019

SMR001566649

SPBio_000755

SPBio_002525

Spectrum2_000828

Spectrum3_001374

Spectrum4_000368

Spectrum5_001553

Spectrum_000668

SR-01000003020-6

Stelazine

Stelazine (*Dihydrochloride*)

Stelazine Concentrate

Stellazine

STK182873

STOCK1S-51401

Synklor

Terfluzine

TFP

Trazine

Trifluoperazin

Trifluoperazin;Trifluoperazina;Trifluoromethylperazine;Trifluoroperazine;Trifluperazine;Trifluroperizine

Trifluoperazina

Trifluoperazina [INN-Spanish]

Trifluoperazina [Italian]

trifluoperazina; trifluoperazine; trifluoperazinum

Trifluoperazine

Trifluoperazine (BAN

Trifluoperazine (dihydrochloride)

Trifluoperazine (INN)

Trifluoperazine 2HCl

Trifluoperazine diHCl

Trifluoperazine HCl

Trifluoperazine Hydrochloride

Trifluoperazine Hydrochloride (FDA

Trifluoperazine [INN:BAN]

Trifluoperazinum

Trifluoperazinum [INN-Latin]

Trifluoromethyl-10-(3'-(1-methyl-4-piperazinyl)propyl)phenothiazine

Trifluoromethylperazine

Trifluoroperazine

Trifluoroperazine Dihydrochloride

Trifluoroperazine Hydrochloride

Trifluperazine

Triflurin

Trifluroperizine

Triftazin

Triftazine

Triperazine

Tripfluoperazine Hydrochloride

Triphtazin

Triphtazine

Triphthasine

Triphthazine

Triphthazine Dihydrochloride

Tryptazine

Tryptazine Dihydrochloride

UNII-214IZI85K3

USP

USP); Trifluoperazine (BAN

USP); Trifluoperazine Maleate (JAN)

Download: MOL2 SDF SMILES Flexibase

Annotations

Vendors

Physical Representations

Type pH range xlogP Des A‑Pol Apolar desolvation (kcal/mol) Des Pol Polar desolvation (kcal/mol) H Don H-bond donors H Acc H-bond acceptors Chg Net charge tPSA (Ų) MWT Molecular weight (g/mol) RB Rotatable bonds DL
Ref Reference (pH 7) 5.14 11.43 -38.84 1 3 1 13 408.513 5
Hi High (pH 8-9.5) 5.14 9.06 -5.72 0 3 0 11 407.505 5
Mid Mid (pH 6-8) 5.14 11.32 -44.3 1 3 1 13 408.513 5

Vendor Notes

Note Type Comments Provided By
ALOGPS_SOLUBILITY 8.76e-03 g/l DrugBank-approved
purity 9.500000000000000e+001 Enamine Building Blocks Enamine Building Blocks
therap antipsychotic MicroSource Spectrum
Therapy Calmodulin antagonist; dopamine receptor antagonist; antipsychotic; sedative SMDC Iconix
UniProt Database Links CASQ1_RABIT; CDPK1_PLAF7; CDPK1_PLAFK; CDPK1_PLAYO; DSPA_SYNY3; ODB2_ARATH ChEBI
Target Dopamine Receptor Selleck Chemicals
Patent Database Links EP1181933; US2007212428 ChEBI
Patent Database Links EP1547650; EP1627639; EP1754712; EP1808173; EP1815846; EP1815854; EP1829527; EP1829528; EP1829534; EP1844769; EP1923702; EP1990639; US2004132722; US2004142904; US2005009870; US2005014786; US2005080075; US2005080087; US2006166974; US2007203119; US200722537 ChEBI
PUBCHEM_SUBSTANCE_COMMENT NCC_SAMPLE_SUPPLIER : Tocris Cookson Ltd.; NCC_SUPPLIER_STRUCTURE_ID : 100741; 2 hydrogen chloride NIH Clinical Collection via PubChem
Target Others Selleck Chemicals
PUBCHEM_SUBSTANCE_COMMENT SAMPLE_SUPPLIER: Tocris Bioscience; SUPPLIER_STRUCTURE_ID: 100741; SALT: 2 hydrogen chloride NIH Clinical Collection via PubChem
Indications schizophrenia KeyOrganics Bioactives

Activity (Go SEA)

Clustered Target Annotations
Code Description Organism Class Affinity (nM) LE (kcal/mol/atom) Type
5HT1A-1-E Serotonin 1a (5-HT1a) Receptor (cluster #1 Of 4), Eukaryotic Eukaryotes 411 0.32 Binding ≤ 10μM
5HT2A-1-E Serotonin 2a (5-HT2a) Receptor (cluster #1 Of 3), Eukaryotic Eukaryotes 5 0.42 Binding ≤ 10μM
5HT2B-2-E Serotonin 2b (5-HT2b) Receptor (cluster #2 Of 4), Eukaryotic Eukaryotes 5 0.42 Binding ≤ 10μM
5HT2C-2-E Serotonin 2c (5-HT2c) Receptor (cluster #2 Of 3), Eukaryotic Eukaryotes 5 0.42 Binding ≤ 10μM
BGLR-2-E Beta-glucuronidase (cluster #2 Of 2), Eukaryotic Eukaryotes 7800 0.26 Binding ≤ 10μM
CALM-2-E Calmodulin (cluster #2 Of 2), Eukaryotic Eukaryotes 1000 0.30 Binding ≤ 10μM
EBP-1-E 3-beta-hydroxysteroid-delta(8),delta(7)-isomerase (cluster #1 Of 1), Eukaryotic Eukaryotes 8 0.40 Binding ≤ 10μM
LYSC1-1-E Lysozyme C (cluster #1 Of 2), Eukaryotic Eukaryotes 9000 0.25 Binding ≤ 10μM
MDR1-2-E P-glycoprotein 1 (cluster #2 Of 3), Eukaryotic Eukaryotes 6500 0.26 Binding ≤ 10μM
SCN1A-1-E Sodium Channel Protein Type I Alpha Subunit (cluster #1 Of 2), Eukaryotic Eukaryotes 5000 0.27 Binding ≤ 10μM
SCN2A-1-E Sodium Channel Protein Type II Alpha Subunit (cluster #1 Of 2), Eukaryotic Eukaryotes 5000 0.27 Binding ≤ 10μM
SCN3A-1-E Sodium Channel Protein Type III Alpha Subunit (cluster #1 Of 2), Eukaryotic Eukaryotes 5000 0.27 Binding ≤ 10μM
SCN8A-1-E Sodium Channel Protein Type VIII Alpha Subunit (cluster #1 Of 2), Eukaryotic Eukaryotes 5000 0.27 Binding ≤ 10μM
SGMR1-1-E Sigma Opioid Receptor (cluster #1 Of 6), Eukaryotic Eukaryotes 15 0.39 Binding ≤ 10μM
DRD2-14-E Dopamine D2 Receptor (cluster #14 Of 24), Eukaryotic Eukaryotes 2 0.43 Binding ≤ 10μM
ERG2-2-F C-8 Sterol Isomerase (cluster #2 Of 2), Fungal Fungi 500 0.32 Binding ≤ 10μM
PDR5-1-F Pleiotropic ABC Efflux Transporter Of Multiple Drugs (cluster #1 Of 1), Fungal Fungi 1400 0.29 Binding ≤ 10μM
Z104304-1-O Adrenergic Receptor Alpha-1 (cluster #1 Of 3), Other Other 350 0.32 Binding ≤ 10μM
Z100748-2-O Neutrophils (cluster #2 Of 2), Other Other 6600 0.26 Functional ≤ 10μM
Z50380-1-O Mycobacterium Smegmatis (cluster #1 Of 4), Other Other 3150 0.28 Functional ≤ 10μM
Z50425-3-O Plasmodium Falciparum (cluster #3 Of 22), Other Other 6000 0.26 Functional ≤ 10μM
Z50597-1-O Rattus Norvegicus (cluster #1 Of 12), Other Other 6600 0.26 Functional ≤ 10μM
A3EZI9-1-V Hepatitis C Virus NS3 Protease/helicase (cluster #1 Of 3), Viral Viruses 700 0.31 Binding ≤ 10μM
ChEMBL Target Annotations
Uniprot Swissprot Description Affinity (nM) LE (kcal/mol/atom) Type
EBP_HUMAN Q15125 3-beta-hydroxysteroid-delta(8),delta(7)-isomerase, Human 8 0.40 Binding ≤ 1μM
Z104304 Z104304 Adrenergic Receptor Alpha-1 29.3 0.38 Binding ≤ 1μM
ERG2_YEAST P32352 C-8 Sterol Isomerase, Yeast 500 0.32 Binding ≤ 1μM
CALM_HUMAN P62158 Calmodulin, Human 1000 0.30 Binding ≤ 1μM
DRD2_RAT P61169 Dopamine D2 Receptor, Rat 0.5322 0.46 Binding ≤ 1μM
A3EZI9_9HEPC A3EZI9 Hepatitis C Virus NS3 Protease/helicase, 9hepc 700 0.31 Binding ≤ 1μM
5HT1A_RAT P19327 Serotonin 1a (5-HT1a) Receptor, Rat 411 0.32 Binding ≤ 1μM
5HT2A_RAT P14842 Serotonin 2a (5-HT2a) Receptor, Rat 1.043 0.45 Binding ≤ 1μM
5HT2B_RAT P30994 Serotonin 2b (5-HT2b) Receptor, Rat 1.043 0.45 Binding ≤ 1μM
5HT2C_RAT P08909 Serotonin 2c (5-HT2c) Receptor, Rat 1.043 0.45 Binding ≤ 1μM
SGMR1_HUMAN Q99720 Sigma Opioid Receptor, Human 15 0.39 Binding ≤ 1μM
EBP_HUMAN Q15125 3-beta-hydroxysteroid-delta(8),delta(7)-isomerase, Human 8 0.40 Binding ≤ 10μM
Z104304 Z104304 Adrenergic Receptor Alpha-1 29.3 0.38 Binding ≤ 10μM
BGLR_RAT P06760 Beta-glucuronidase, Rat 7800 0.26 Binding ≤ 10μM
ERG2_YEAST P32352 C-8 Sterol Isomerase, Yeast 500 0.32 Binding ≤ 10μM
CALM_HUMAN P62158 Calmodulin, Human 1000 0.30 Binding ≤ 10μM
DRD2_RAT P61169 Dopamine D2 Receptor, Rat 0.5322 0.46 Binding ≤ 10μM
A3EZI9_9HEPC A3EZI9 Hepatitis C Virus NS3 Protease/helicase, 9hepc 700 0.31 Binding ≤ 10μM
LYSC1_RAT P00697 Lysozyme C, Rat 9000 0.25 Binding ≤ 10μM
MDR1_HUMAN P08183 P-glycoprotein 1, Human 6500 0.26 Binding ≤ 10μM
PDR5_YEAST P33302 Pleiotropic ABC Efflux Transporter Of Multiple Drugs, Yeast 1400 0.29 Binding ≤ 10μM
5HT1A_RAT P19327 Serotonin 1a (5-HT1a) Receptor, Rat 411 0.32 Binding ≤ 10μM
5HT2A_RAT P14842 Serotonin 2a (5-HT2a) Receptor, Rat 1.043 0.45 Binding ≤ 10μM
5HT2B_RAT P30994 Serotonin 2b (5-HT2b) Receptor, Rat 1.043 0.45 Binding ≤ 10μM
5HT2C_RAT P08909 Serotonin 2c (5-HT2c) Receptor, Rat 1.043 0.45 Binding ≤ 10μM
SGMR1_HUMAN Q99720 Sigma Opioid Receptor, Human 15 0.39 Binding ≤ 10μM
SCN1A_HUMAN P35498 Sodium Channel Protein Type I Alpha Subunit, Human 5000 0.27 Binding ≤ 10μM
SCN2A_HUMAN Q99250 Sodium Channel Protein Type II Alpha Subunit, Human 5000 0.27 Binding ≤ 10μM
SCN3A_HUMAN Q9NY46 Sodium Channel Protein Type III Alpha Subunit, Human 5000 0.27 Binding ≤ 10μM
SCN8A_HUMAN Q9UQD0 Sodium Channel Protein Type VIII Alpha Subunit, Human 5000 0.27 Binding ≤ 10μM
Z50380 Z50380 Mycobacterium Smegmatis 3150 0.28 Functional ≤ 10μM
Z100748 Z100748 Neutrophils 2700 0.28 Functional ≤ 10μM
Z50425 Z50425 Plasmodium Falciparum 3981.07171 0.27 Functional ≤ 10μM
Z50597 Z50597 Rattus Norvegicus 2700 0.28 Functional ≤ 10μM

Reactome Annotations from Targets (via Uniprot)

Description Species
Abacavir transmembrane transport
ABC-family proteins mediated transport
Activation of Ca-permeable Kainate Receptor
Activation of CaMK IV
Antigen activates B Cell Receptor (BCR) leading to generation of second messenge
Ca2+ pathway
Calmodulin induced events
CaM pathway
Cam-PDE 1 activation
CaMK IV-mediated phosphorylation of CREB
Cholesterol biosynthesis
CREB phosphorylation through the activation of CaMKII
CREB phosphorylation through the activation of CaMKK
DARPP-32 events
Dopamine receptors
eNOS activation
FCERI mediated Ca+2 mobilization
G alpha (i) signalling events
G alpha (q) signalling events
Glycogen breakdown (glycogenolysis)
Inactivation, recovery and regulation of the phototransduction cascade
Interaction between L1 and Ankyrins
Platelet degranulation
Ras activation uopn Ca2+ infux through NMDA receptor
Serotonin receptors
Smooth Muscle Contraction
Synthesis of IP3 and IP4 in the cytosol
Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation
Transcriptional activation of mitochondrial biogenesis
Translocation of GLUT4 to the plasma membrane
VEGFR2 mediated cell proliferation
VEGFR2 mediated vascular permeability

Analogs ( Draw Identity 99% 90% 80% 70% )